🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

So grateful to be surrounded by such hopeful humans and an amazing team on Christmas Day! Thank you team ICET and #moffitt

Go go Moffitt Research Moffitt Cancer Center what a great session at #Tandem24 on where the future of allo is going congratulations Dr Hany Elmariah!!!

So joyful to be riding out the hurricane with the amazing team here keeping our patients safe and well!

So touched by the amazing resilience of Floridians, the incredible preparation of Moffitt Cancer Center and the prayers and thoughts of friends, families, patients and colleagues pouring in from around the globe. We will weather this storm. #floridastrong

Ciara Freeman will report several genomic determinants of resistance to anti-BCMA CART #mmsm 🔥 #WGS can predict all refractory cases! Dense work that was possible only thanks to great collaboration between Moffitt Cancer Center Memorial Sloan Kettering Cancer Center U Calgary Sylvester Comprehensive Cancer Center #ASH24 3/10

Happy to be asked to share what’s exciting for patients at #ASH24 with #healthtree a fantastic resource making sense of MM for patients! Thank you for all you do!

So fun to be a part of the trainee event today - such a success and wonderful to meet the next generation of ASH members in the making!!!

What fascinating data on the impact of ST3GAL1 and its influence on daratumumab responses!!! Fantastic presentation 🇮🇪 not to mention great representation from my Alma mater Michael O'Dwyer

1/ #ASHkudos to Ciara Freeman for leading one of the most exciting orals of #ASH24! Phase 2 trial of anito-cel as likely next BCMA CAR-T to get approved. Setting stage - reminding us how different the CAR looks and how study was designed. Only 1 out of 118 manuf failures!

2/ #ASH24 moving to Ciara Freeman anito-cel efficacy and safety. Impressive efficacy and safety to date! 93% MRD-neg. 3 deaths: one from CRS, one from infection, and one from BMBx bleeding during workup for IEC-HS. Excited to see iMMagine-3 and hopeful approval soon! #MMsm

LIVE from #ASH24, in a packed out session Ciara Freeman, MD (Ciara Freeman) presents early trial results that show high success rates and manageable side effects for advanced multiple myeloma. ➡️ In the iMMagine-1 trial, anito-cel showed impressive response rates of 95%, with

My 12th randomized trial. #ASH24 Proud of this one 👇

Increased serum B-cell maturation antigen levels evaluated with an Elecsys-based serum B-cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myeloma buff.ly/4ftN13z

Excited to share our latest work in @BloodJournal! 📢 We demonstrate how soluble BCMA (sBCMA) quantification and MTV from SOC PET can predict tumor burden, response, and toxicity from CAR-T! True multidisciplinary effort! ashpublications.org/blood/article/… Moffitt Cancer Center Moffitt Research

Excited to share our latest work in @BloodJournal!tiny fragments scraped from archived SOC pathology slides can generate powerful gene expression profiles—showcasing how to unlock potential from archived material to identify those at greatest risk.  ashpublications.org/blood/article-…

Thanks to all my amazing Moffitt Cancer Center collaborators - but special thanks go out to Dietrich Werner Idiaquez for your BEAUTIFUL images of sBCMA expressing myeloma cells that grace the cover of Blood this week

Excited to share our work on the T cell differences when you compare post induction T cells and those in later lines - earlier derived T cells will likely be more potent with key impact on CAR/TCE outcomes and potentially toxicity…. cell.com/molecular-ther…

Reposting to tag the dream team—grateful to work with this crew on our Molecular Therapy paper: Frederick L. Locke Julieta Abraham Miranda, Pharm, PhD Hien D. Liu, MD Moffitt Cancer Center #CART #Immunotherapy

In Science, researchers present a new method to safely and preferentially generate CAR T cells directly inside the body using targeted lipid nanoparticles that deliver mRNA directly to T cells. The approach showed rapid and sustained immune reprogramming in preclinical models,

Excited to be discussing the highlights of #EHA2025 with two of my favorite #woMMen. Join us for what should be a fantastic session full of insights and discussion! 🔗 Register here: url.us.m.mimecastprotect.com/s/vgmVCOYJVxFp…